Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elaine K Allan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Blood|January 11, 2007
Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cellsHeather G Jørgensen, Elaine K Allan, Niove E Jordanides, et al.
Biomedical Chromatography : BMC|August 11, 2011
Investigation into omacetaxine solution stability for in vitro studyLamin Marenah, Elaine K Allan, Joanne C Mountford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylateHeather G Jørgensen, Mhairi Copland, Elaine K Allan, et al.
Blood|January 10, 2002
Alpha1-acid glycoprotein expressed in the plasma of chronic myeloid leukemia patients does not mediate significant in vitro resistance to STI571Heather G Jørgensen, Moira A Elliott, Elaine K Allan, et al.
Blood|December 25, 2007
BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitorsMhairi Copland, Francesca Pellicano, Linda Richmond, et al.
Experimental Hematology|October 13, 2005
Enhanced CML stem cell elimination in vitro by bryostatin priming with imatinib mesylateHeather G Jørgensen, Elaine K Allan, Joanne C Mountford, et al.
Blood|September 18, 2013
Autocrine TNF-α production supports CML stem and progenitor cell survival and enhances their proliferationPaolo Gallipoli, Francesca Pellicano, Heather Morrison, et al.
Blood|February 14, 2006
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fractionMhairi Copland, Ashley Hamilton, Lucy J Elrick, et al.
Blood|January 14, 2010
Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cellsNicholas B Heaney, Francesca Pellicano, Bin Zhang, et al.
Blood|December 21, 2011
Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survivalAshley Hamilton, G Vignir Helgason, Mirle Schemionek, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Blood|January 11, 2007
Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cellsHeather G Jørgensen, Elaine K Allan, Niove E Jordanides, et al.
Biomedical Chromatography : BMC|August 11, 2011
Investigation into omacetaxine solution stability for in vitro studyLamin Marenah, Elaine K Allan, Joanne C Mountford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylateHeather G Jørgensen, Mhairi Copland, Elaine K Allan, et al.
Blood|January 10, 2002
Alpha1-acid glycoprotein expressed in the plasma of chronic myeloid leukemia patients does not mediate significant in vitro resistance to STI571Heather G Jørgensen, Moira A Elliott, Elaine K Allan, et al.
Blood|December 25, 2007
BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitorsMhairi Copland, Francesca Pellicano, Linda Richmond, et al.
Experimental Hematology|October 13, 2005
Enhanced CML stem cell elimination in vitro by bryostatin priming with imatinib mesylateHeather G Jørgensen, Elaine K Allan, Joanne C Mountford, et al.
Blood|September 18, 2013
Autocrine TNF-α production supports CML stem and progenitor cell survival and enhances their proliferationPaolo Gallipoli, Francesca Pellicano, Heather Morrison, et al.
Blood|February 14, 2006
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fractionMhairi Copland, Ashley Hamilton, Lucy J Elrick, et al.
Blood|January 14, 2010
Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cellsNicholas B Heaney, Francesca Pellicano, Bin Zhang, et al.
Blood|December 21, 2011
Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survivalAshley Hamilton, G Vignir Helgason, Mirle Schemionek, et al.
Pageof 2